Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506948 | SCV000605614 | uncertain significance | not provided | 2017-05-24 | criteria provided, single submitter | clinical testing | The p.Ala575Gly variant (rs71524360) has not been reported in the medical literature in association with hearing loss nor has it been previously identified in our laboratory. It is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in Latino populations of 0.10% (identified in 35 out of 34,416 chromosomes, including 1 homozygote). The alanine at codon 575 is moderately conserved considering 13 species (Alamut software v2.9), and computational analyses return mixed results regarding the effect of this variant on WFS1 protein structure/function (SIFT: tolerated, PolyPhen2: benign, and Mutation Taster: disease causing). Thus, based on the available information, the clinical significance of the p.Ala575Gly variant cannot be determined with certainty. |
Fulgent Genetics, |
RCV000765784 | SCV000897173 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000506948 | SCV002370436 | likely benign | not provided | 2023-10-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000506948 | SCV002498917 | uncertain significance | not provided | 2022-09-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26435059) |